Our results show that high tumor abundance of the IL2NK phenotype and transcripts for the KLRK1, CD160, and TNFRSF14 receptors are associated with improved survival, whereas high tumor abundance of the SPANK and PDGFD transcripts is associated with poor survival. Here, CD160 is linked to neoplasm.